BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 10680925)

  • 21. Asymmetric hearing loss: rule 3,000 for screening vestibular schwannoma.
    Saliba I; Martineau G; Chagnon M
    Otol Neurotol; 2009 Jun; 30(4):515-21. PubMed ID: 19395982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cochlear origin of early hearing loss in vestibular schwannoma.
    Gouveris HT; Victor A; Mann WJ
    Laryngoscope; 2007 Apr; 117(4):680-3. PubMed ID: 17429875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acoustic neuromas presenting with normal or symmetrical hearing: factors associated with diagnosis and outcome.
    Lustig LR; Rifkin S; Jackler RK; Pitts LH
    Am J Otol; 1998 Mar; 19(2):212-8. PubMed ID: 9520059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and management of intralabyrinthine schwannomas.
    Green JD; McKenzie JD
    Laryngoscope; 1999 Oct; 109(10):1626-31. PubMed ID: 10522933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conservative management versus stereotactic radiation for vestibular schwannomas: a meta-analysis of patients with more than 5 years' follow-up.
    Maniakas A; Saliba I
    Otol Neurotol; 2012 Feb; 33(2):230-8. PubMed ID: 22222572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preservation of hearing in vestibular schwannomas treated by radiosurgery using Leksell Gamma Knife: preliminary report of a prospective Belgian clinical study.
    Delbrouck C; Hassid S; Massager N; Choufani G; David P; Devriendt D; Levivier M
    Acta Otorhinolaryngol Belg; 2003; 57(3):197-204. PubMed ID: 14571654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acoustic neuromas and serviceable hearing: choosing the surgical approach].
    Bozorg-Grayeli A; Kalamarides M; Tormin-Borges-Crosara PF; Bouccara D; Rey A; Sterkers O
    Neurochirurgie; 2002 Dec; 48(6):479-86. PubMed ID: 12595803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of intralabyrinthine schwannomas.
    Di Lella F; Dispenza F; De Stefano A; Falcioni M; Sanna M
    Auris Nasus Larynx; 2007 Dec; 34(4):459-63. PubMed ID: 17467216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathologic markers of hearing loss in intralabyrinthine schwannomas: implications for management.
    Santos F; Linthicum FH; House JW; Wilkinson EP
    Otol Neurotol; 2011 Dec; 32(9):1542-7. PubMed ID: 22072265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of two radiologic methods for measuring the size and growth rate of extracanalicular vestibular schwannomas.
    Walsh RM; Bath AP; Bance ML; Keller A; Rutka JA
    Am J Otol; 2000 Sep; 21(5):716-21. PubMed ID: 10993465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term hearing preservation in vestibular schwannoma.
    Stangerup SE; Thomsen J; Tos M; Cayé-Thomasen P
    Otol Neurotol; 2010 Feb; 31(2):271-5. PubMed ID: 19887973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rate of Initial Hearing Loss During Early Observation Predicts Time to Non-Serviceable Hearing in Patients With Conservatively Managed Sporadic Vestibular Schwannoma.
    Carlson ML; Dowling EM; Lohse CM; O'Connell BP; Driscoll CLW; Haynes DS; Link MJ; Hunter JB
    Otol Neurotol; 2019 Dec; 40(10):e1012-e1017. PubMed ID: 31634279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intra-labyrinthine schwannomas: a report of two cases].
    Boutin P; Guth A; Bouccara D; el Garem H; Rey A; Sterkers O
    Ann Otolaryngol Chir Cervicofac; 1998 Feb; 115(1):35-41. PubMed ID: 9765709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of fundal extension on hearing after surgery for vestibular schwannomas.
    Nguyen QT; Wu AP; Mastrodimos BJ; Cueva RA
    Otol Neurotol; 2012 Apr; 33(3):455-8. PubMed ID: 22334158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hearing outcomes after stereotactic radiosurgery for unilateral intracanalicular vestibular schwannomas: implication of transient volume expansion.
    Kim YH; Kim DG; Han JH; Chung HT; Kim IK; Song SW; Park JH; Kim JW; Kim YH; Park CK; Kim CY; Paek SH; Jung HW
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):61-7. PubMed ID: 22580122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of hearing loss and radiologic dimensions of vestibular schwannomas (acoustic Neuromas).
    Nadol JB; Diamond PF; Thornton AR
    Am J Otol; 1996 Mar; 17(2):312-6. PubMed ID: 8723968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical acumen and vestibular schwannoma.
    Moffat DA; Baguley DM; Beynon GJ; Da Cruz M
    Am J Otol; 1998 Jan; 19(1):82-7. PubMed ID: 9455955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lesions of the internal auditory canal and cerebellopontine angle in an only hearing ear: is surgery ever advisable?
    Driscoll CL; Jackler RK; Pitts LH; Brackmann DE
    Am J Otol; 2000 Jul; 21(4):573-81. PubMed ID: 10912705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of vestibular dysfunction and hearing loss in intralabyrinthine schwannomas.
    Totten DJ; Manzoor NF; Perkins EL; Cass ND; Bennett ML; Haynes DS
    Am J Otolaryngol; 2021; 42(4):102984. PubMed ID: 33610925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.